Hepatic Artery Infusional Chemotherapy

Surgical Clinics of North America

Volumn 96, Issue 2, 2016, Pages 341-355

  Lewis, Heather L ^a   Bloomston, Mark ^b  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^b 21ST CENTURY ONCOLOGY   (United States)

Author keywords

Hepatic artery infusion pump; Hepatic metastases; Regional therapy

Indexed keywords

ALKALINE PHOSPHATASE; ANTIBIOTIC AGENT; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; DEXAMETHASONE; FIBRINOLYTIC AGENT; FLOXURIDINE; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; MACROSALB TC 99M; OXALIPLATIN; ANTINEOPLASTIC AGENT;

ADJUVANT THERAPY; ARTERY CATHETER; ARTERY DISSECTION; ARTERY THROMBOSIS; ARTICLE; BILE DUCT DISEASE; BILIARY SCLEROSIS; CATHETER THROMBOSIS; CELLULITIS; COLORECTAL CANCER; COLORECTAL LIVER METASTASIS; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; DEVICE INFECTION; DEVICE SAFETY; DIARRHEA; DISEASE FREE SURVIVAL; DRUG CLEARANCE; DRUG DOSE REDUCTION; DRUG INFUSION; DRUG SOLUBILITY; DRUG TUMOR LEVEL; FIRST PASS EFFECT; GASTRITIS; HEPATIC ARTERY; HUMAN; HYPERTRANSAMINASEMIA; INFUSION PUMP; LAPAROSCOPIC SURGERY; LAPAROTOMY; LIVER BLOOD FLOW; LIVER RESECTION; LIVER SCINTISCANNING; MEDICAL DEVICE COMPLICATION; MEDICAL ONCOLOGIST; MEDICAL RESEARCH; MORBIDITY; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PATIENT COMPLIANCE; PATIENT MONITORING; PEPTIC ULCER; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); POSTOPERATIVE CARE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENCE FREE SURVIVAL; SEROMA; SURGICAL ONCOLOGIST; SURGICAL TECHNIQUE; TREATMENT OUTCOME; TUMOR VOLUME; WOUND DEHISCENCE; COLORECTAL TUMOR; DEVICES; INTRAARTERIAL DRUG ADMINISTRATION; LIVER NEOPLASMS; PATHOLOGY; SECONDARY;

ANTINEOPLASTIC AGENTS; COLORECTAL NEOPLASMS; HEPATIC ARTERY; HUMANS; INFUSIONS, INTRA-ARTERIAL; LIVER NEOPLASMS;

EID: 84961674918     PISSN: 00396109     EISSN: 15583171     Source Type: Journal    
DOI: 10.1016/j.suc.2015.11.002     Document Type: Review

References (47)

1. Siegel R.L., Miller K.D., Jemal A. Cancer statistics, 2015. CA Cancer J Clin 2015, 65(1):5-29.
2. Kopetz S., Chang G.J., Overman M.J., et al. Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy. J Clin Oncol 2009, 27(22):3677-3683.
3. Breedis C., Young G. The blood supply of neoplasms in the liver. Am J Pathol 1954, 30(5):969-977.
4. Sullivan R.D., Norcross J.W., Watkins E. Chemotherapy of metastatic liver cancer by prolonged hepatic-artery infusion. N Engl J Med 1964, 270:321-327.
5. Ensminger W.D., Rosowsky A., Raso V., et al. A clinical-pharmacological evaluation of hepatic arterial infusions of 5-fluoro-2'-deoxyuridine and 5-fluorouracil. Cancer Res 1978, 38(11 Pt 1):3784-3792.
6. Sigurdson E.R., Ridge J.A., Kemeny N., et al. Tumor and liver drug uptake following hepatic artery and portal vein infusion. J Clin Oncol 1987, 5(11):1836-1840.
7. Daly J.M., Kemeny N., Sigurdson E., et al. Regional infusion for colorectal hepatic metastases. A randomized trial comparing the hepatic artery with the portal vein. Arch Surg 1987, 122(11):1273-1277.
8. Dizon D.S., Schwartz J., Kemeny N. Regional chemotherapy: a focus on hepatic artery infusion for colorectal cancer liver metastases. Surg Oncol Clin N Am 2008, 17(4):759-771. viii.
9. Buchwald H., Grage T.B., Vassilopoulos P.P., et al. Intraarterial infusion chemotherapy for hepatic carcinoma using a totally implantable infusion pump. Cancer 1980, 45(5):866-869.
10. Bacchetti S., Pasqual E., Crozzolo E., et al. Intra-arterial hepatic chemotherapy for unresectable colorectal liver metastases: a review of medical devices complications in 3172 patients. Med Devices (Auckl) 2009, 2:31-40.
11. Curley S.A., Chase J.L., Roh M.S., et al. Technical considerations and complications associated with the placement of 180 implantable hepatic arterial infusion devices. Surgery 1993, 114(5):928-935.
12. Kemeny M.M. The surgical aspects of the totally implantable hepatic artery infusion pump. Arch Surg 2001, 136(3):348-352.
13. Arru M., Aldrighetti L., Gremmo F., et al. Arterial devices for regional hepatic chemotherapy: transaxillary versus laparotomic access. J Vasc Access 2000, 1(3):93-99.
14. Cheng J., Hong D., Zhu G., et al. Laparoscopic placement of hepatic artery infusion pumps: technical considerations and early results. Ann Surg Oncol 2004, 11(6):589-597.
15. Feliciotti F., Paganini A., Guerrieri M., et al. Laparoscopic intra-arterial catheter implantation for regional chemotherapy of liver metastasis. Surg Endosc 1996, 10(4):449-452.
16. Urbach D.R., Herron D.M., Khajanchee Y.S., et al. Laparoscopic hepatic artery infusion pump placement. Arch Surg 2001, 136(6):700-704.
17. Hellan M., Pigazzi A. Robotic-assisted placement of a hepatic artery infusion catheter for regional chemotherapy. Surg Endosc 2008, 22(2):548-551.
18. Michels N.A. Newer anatomy of the liver and its variant blood supply and collateral circulation. Am J Surg 1966, 112(3):337-347.
19. Yezhelyev M., Osgood M., Egnatashvili V., et al. Saphenous vein graft conduits for insertion of hepatic arterial infusion pumps in patients with abnormal hepatic arterial anatomy. J Surg Oncol 2008, 97(1):85-89.
20. Skitzki J.J., Chang A.E. Hepatic artery chemotherapy for colorectal liver metastases: technical considerations and review of clinical trials. Surg Oncol 2002, 11(3):123-135.
21. Ammori J.B., D'Angelica M.I., Fong Y., et al. Hepatic artery infusional chemotherapy in patients with unresectable colorectal liver metastases and extrahepatic disease. J Surg Oncol 2012, 106(8):953-958.
22. Hohn D.C., Stagg R.J., Price D.C., et al. Avoidance of gastroduodenal toxicity in patients receiving hepatic arterial 5-fluoro-2'-deoxyuridine. J Clin Oncol 1985, 3(9):1257-1260.
23. Kemeny M.M., Battifora H., Blayney D.W., et al. Sclerosing cholangitis after continuous hepatic artery infusion of FUDR. Ann Surg 1985, 202(2):176-181.
24. Perez D.R., Kemeny N.E., Brown K.T., et al. Angiographic identification of extrahepatic perfusion after hepatic arterial pump placement: implications for surgical prevention. HPB (Oxford) 2014, 16(8):744-748.
25. Power D.G., Kemeny N.E. The role of floxuridine in metastatic liver disease. Mol Cancer Ther 2009, 8(5):1015-1025.
26. Ito K., Ito H., Kemeny N.E., et al. Biliary sclerosis after hepatic arterial infusion pump chemotherapy for patients with colorectal cancer liver metastasis: incidence, clinical features, and risk factors. Ann Surg Oncol 2012, 19(5):1609-1617.
27. Kemeny N., Seiter K., Niedzwiecki D., et al. A randomized trial of intrahepatic infusion of fluorodeoxyuridine with dexamethasone versus fluorodeoxyuridine alone in the treatment of metastatic colorectal cancer. Cancer 1992, 69(2):327-334.
28. Allen P.J., Nissan A., Picon A.I., et al. Technical complications and durability of hepatic artery infusion pumps for unresectable colorectal liver metastases: an institutional experience of 544 consecutive cases. J Am Coll Surg 2005, 201(1):57-65.
29. Scaife C.L., Curley S.A., Izzo F., et al. Feasibility of adjuvant hepatic arterial infusion of chemotherapy after radiofrequency ablation with or without resection in patients with hepatic metastases from colorectal cancer. Ann Surg Oncol 2003, 10(4):348-354.
30. Vigano L., Ferrero A., Lo Tesoriere R., et al. Liver surgery for colorectal metastases: results after 10 years of follow-up. Long-term survivors, late recurrences, and prognostic role of morbidity. Ann Surg Oncol 2008, 15(9):2458-2464.
31. Fong Y., Cohen A.M., Fortner J.G., et al. Liver resection for colorectal metastases. J Clin Oncol 1997, 15(3):938-946.
32. Kemeny N., Huang Y., Cohen A.M., et al. Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N Engl J Med 1999, 341(27):2039-2048.
33. Kemeny N.E., Gonen M. Hepatic arterial infusion after liver resection. N Engl J Med 2005, 352(7):734-735.
34. Kemeny N., Jarnagin W., Gonen M., et al. Phase I/II study of hepatic arterial therapy with floxuridine and dexamethasone in combination with intravenous irinotecan as adjuvant treatment after resection of hepatic metastases from colorectal cancer. J Clin Oncol 2003, 21(17):3303-3309.
35. Kemeny N., Capanu M., D'Angelica M., et al. Phase I trial of adjuvant hepatic arterial infusion (HAI) with floxuridine (FUDR) and dexamethasone plus systemic oxaliplatin, 5-fluorouracil and leucovorin in patients with resected liver metastases from colorectal cancer. Ann Oncol 2009, 20(7):1236-1241.
36. House M.G., Kemeny N.E., Gonen M., et al. Comparison of adjuvant systemic chemotherapy with or without hepatic arterial infusional chemotherapy after hepatic resection for metastatic colorectal cancer. Ann Surg 2011, 254(6):851-856.
37. Goere D., Benhaim L., Bonnet S., et al. Adjuvant chemotherapy after resection of colorectal liver metastases in patients at high risk of hepatic recurrence: a comparative study between hepatic arterial infusion of oxaliplatin and modern systemic chemotherapy. Ann Surg 2013, 257(1):114-120.
38. Kemeny N.E., Niedzwiecki D., Hollis D.R., et al. Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481). J Clin Oncol 2006, 24(9):1395-1403.
39. Kerr D.J., McArdle C.S., Ledermann J., et al. Intrahepatic arterial versus intravenous fluorouracil and folinic acid for colorectal cancer liver metastases: a multicentre randomised trial. Lancet 2003, 361(9355):368-373.
40. Lorenz M., Muller H.H. Randomized, multicenter trial of fluorouracil plus leucovorin administered either via hepatic arterial or intravenous infusion versus fluorodeoxyuridine administered via hepatic arterial infusion in patients with nonresectable liver metastases from colorectal carcinoma. J Clin Oncol 2000, 18(2):243-254.
41. Ammori J.B., Kemeny N.E., Fong Y., et al. Conversion to complete resection and/or ablation using hepatic artery infusional chemotherapy in patients with unresectable liver metastases from colorectal cancer: a decade of experience at a single institution. Ann Surg Oncol 2013, 20(9):2901-2907.
42. Power D.G., Kemeny N.E. Chemotherapy for the conversion of unresectable colorectal cancer liver metastases to resection. Crit Rev Oncol Hematol 2011, 79(3):251-264.
43. Cardona K., Donataccio D., Kingham T.P., et al. Treatment of extensive metastatic colorectal cancer to the liver with systemic and hepatic arterial infusion chemotherapy and two-stage hepatic resection: the role of salvage therapy for recurrent disease. Ann Surg Oncol 2014, 21(3):815-821.
44. Kemeny N., Gonen M., Sullivan D., et al. Phase I study of hepatic arterial infusion of floxuridine and dexamethasone with systemic irinotecan for unresectable hepatic metastases from colorectal cancer. J Clin Oncol 2001, 19(10):2687-2695.
45. Kemeny N., Jarnagin W., Paty P., et al. Phase I trial of systemic oxaliplatin combination chemotherapy with hepatic arterial infusion in patients with unresectable liver metastases from colorectal cancer. J Clin Oncol 2005, 23(22):4888-4896.
46. Jarnagin W.R., Schwartz L.H., Gultekin D.H., et al. Regional chemotherapy for unresectable primary liver cancer: results of a phase II clinical trial and assessment of DCE-MRI as a biomarker of survival. Ann Oncol 2009, 20(9):1589-1595.
47. Konstantinidis I.T., Do R.K., Gultekin D.H., et al. Regional chemotherapy for unresectable intrahepatic cholangiocarcinoma: a potential role for dynamic magnetic resonance imaging as an imaging biomarker and a survival update from two prospective clinical trials. Ann Surg Oncol 2014, 21(8):2675-2683.